Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females
This study has been terminated.
( Increased LFTs )
Study NCT00787618   Information provided by Repros Therapeutics Inc.

First Received on November 6, 2008.   Last Updated on August 25, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Renal Function
Additional conditions recognized in this trial
Renal Insufficiency
More general conditions related to this trial
Kidney Diseases
Urologic Diseases
Interventions listed in this trial
50mg of Proellex®
Sponsors listed in this trial
Repros Therapeutics Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services